Accelerating biomedical innovation: a case study of the SPARK program at Stanford University, School of Medicine
Translating academic medical research into new therapies is an important challenge for the biopharmaceutical industry and investment communities, which have historically favored later-stage assets with lower risk and clearer commercial value. The Stanford SPARK program is an innovative model for add...
| Other Authors: | |
|---|---|
| Format: | Article |
| Published: |
Elsevier BV
2019
|
| Online Access: | http://hdl.handle.net/1721.1/120750 |